- Home
- REVB vs ITP Comparison
REVB vs ITP Comparison
Compare REVB & ITP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- ITP
- Stock Information
- Founded
- REVB 2020
- ITP 1996
- Country
- REVB United States
- ITP China
- Employees
- REVB N/A
- ITP N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- ITP Paper
- Sector
- REVB Health Care
- ITP Basic Materials
- Exchange
- REVB Nasdaq
- ITP Nasdaq
- Market Cap
- REVB 2.8M
- ITP 2.6M
- IPO Year
- REVB N/A
- ITP N/A
- Fundamental
- Price
- REVB $2.92
- ITP $0.28
- Analyst Decision
- REVB
- ITP
- Analyst Count
- REVB 0
- ITP 0
- Target Price
- REVB N/A
- ITP N/A
- AVG Volume (30 Days)
- REVB 147.3K
- ITP 122.7K
- Earning Date
- REVB 05-09-2025
- ITP 04-11-2025
- Dividend Yield
- REVB N/A
- ITP N/A
- EPS Growth
- REVB N/A
- ITP N/A
- EPS
- REVB N/A
- ITP N/A
- Revenue
- REVB N/A
- ITP $75,837,943.00
- Revenue This Year
- REVB N/A
- ITP N/A
- Revenue Next Year
- REVB N/A
- ITP N/A
- P/E Ratio
- REVB N/A
- ITP N/A
- Revenue Growth
- REVB N/A
- ITP N/A
- 52 Week Low
- REVB $2.36
- ITP $0.20
- 52 Week High
- REVB $60.80
- ITP $1.07
- Technical
- Relative Strength Index (RSI)
- REVB 45.77
- ITP 50.55
- Support Level
- REVB $2.76
- ITP $0.23
- Resistance Level
- REVB $3.62
- ITP $0.30
- Average True Range (ATR)
- REVB 0.41
- ITP 0.03
- MACD
- REVB 0.02
- ITP 0.01
- Stochastic Oscillator
- REVB 34.12
- ITP 75.22
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It involves in production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments Dongfang Paper and Tengsheng Paper, which produces offset printing paper, corrugating medium paper and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.